Is Lipoprotein(a) a Risk Factor for Blood Clots? Gregory Piazza and Team Publish Landmark Study
Gregory Piazza, Director of the Vascular Medicine Section at Brigham and Women’s Hospital, posted on LinkedIn:
”Lipoprotein(a) is a known risk factor for atherosclerotic cardiovascular disease, including heart attack. Testing for lipoprotein(a) is even a recommendation in some guidelines to identify patients at risk for early heart disease. But is lipoprotein(a) a risk factor for venous thrombosis as well? A recent publication from my group explores the links between lipoprotein(a) and blood clots.”
Read the full article here.
Title: Lipoprotein(a) and Venous Thromboembolism: Association, Causality, and Medications
Authors: Mariana B Pfeferman, Sina Rashedi, Gregory Y H Lip, Christian Weber, Michelle L O’Donoghue, Steven Nissen, Stephen J Nicholls, Pradeep Natarajan, Jorge Plutzky, Peter Libby, Samuel Z Goldhaber, Gregory Piazza, Behnood Bikdeli

Stay updated with Hemostasis Today.
-
Mar 16, 2026, 13:32Filippo Cademartiri: Inflammation vs Cholesterol as Driver of Residual ASCVD Risk
-
Mar 16, 2026, 13:12Mariia Kumskova։ New Insights Into Platelet Dysfunction in Ehlers-Danlos Syndrome
-
Mar 15, 2026, 15:55Rare Diseases, Plasma-Derived Medicines and the Elephant in the Room – Part 2
-
Mar 15, 2026, 14:09Abdul Mannan: A Red Eye, a Blood Clot, and Ibrutinib – The Clinical Tightrope
-
Mar 15, 2026, 14:02Denise M: Precision Hemostasis in Patient Blood Management
-
Mar 15, 2026, 13:57Abdulrahman Nasiri: D14 Bone Marrow Biopsy in AML Induction in the Era of Targeted Therapies
-
Mar 15, 2026, 13:52Valentin Ortiz-Maldonado: High-Impact Innovation in CAR-T Therapy Can Emerge From Academic Programmes
-
Mar 15, 2026, 13:45Tareq Abadl: Has Anyone Here Ever Taken an ALP Test Before?
-
Mar 14, 2026, 21:30Ayman Elbadawi: Why Does Stent Thrombosis Still Occur? Insights from the NCDR Data